名臣健康
(002919)
| 流通市值：41.55亿 | | | 总市值：41.95亿 |
| 流通股本：2.64亿 | | | 总股本：2.67亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 361,419,226.73 | 1,380,254,020.51 | 984,704,973.19 | 664,655,853.45 |
| 营业收入 | 361,419,226.73 | 1,380,254,020.51 | 984,704,973.19 | 664,655,853.45 |
| 二、营业总成本 | 340,518,894.23 | 1,279,892,804.36 | 852,236,672.12 | 588,280,314.09 |
| 营业成本 | 157,926,236.96 | 655,621,816.29 | 377,292,545.81 | 246,416,611.16 |
| 税金及附加 | 724,315.21 | 5,358,600.75 | 3,636,692.94 | 2,247,267.17 |
| 销售费用 | 146,167,531.44 | 443,621,398.89 | 346,351,879.32 | 246,245,460.14 |
| 管理费用 | 22,038,110.4 | 106,043,406.6 | 76,435,382.09 | 55,062,772.37 |
| 研发费用 | 13,676,400.02 | 69,410,518.02 | 48,895,920.66 | 38,069,021.81 |
| 财务费用 | -13,699.8 | -162,936.19 | -375,748.7 | 239,181.44 |
| 其中:利息费用 | 232,511.07 | 1,584,358.09 | 1,162,930.05 | 909,104.21 |
| 其中:利息收入 | 198,709.94 | 1,051,535.16 | 842,153.63 | 673,202.65 |
| 加:公允价值变动收益 | 139,580.85 | 376,726.21 | 145,223.49 | 65,946.36 |
| 加:投资收益 | 79,033.26 | 147,045.64 | 146,789.23 | 84,817.74 |
| 资产处置收益 | -182,061.13 | 4,381,300.68 | 3,782,754.23 | 3,633,287 |
| 资产减值损失(新) | - | -24,415,616.12 | -5,226,222.62 | -2,669,415.12 |
| 信用减值损失(新) | -6,417,941.31 | -49,924,933.59 | -22,091,174.49 | -11,185,275.03 |
| 其他收益 | 255,364.28 | 406,211.75 | 248,650.07 | 241,540.49 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 14,774,308.45 | 31,331,950.72 | 109,474,320.98 | 66,546,440.8 |
| 加:营业外收入 | 5,009.82 | 866,747.34 | 126,226.41 | 101,014.41 |
| 减:营业外支出 | 1,560.84 | 4,719,881.01 | 2,785,152.55 | 1,411,408.83 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 14,777,757.43 | 27,478,817.05 | 106,815,394.84 | 65,236,046.38 |
| 减:所得税费用 | 2,030,124.67 | -19,238,335.84 | 10,025,078.73 | 4,871,403.54 |
| 六、净利润 | 12,747,632.76 | 46,717,152.89 | 96,790,316.11 | 60,364,642.84 |
| 持续经营净利润 | 12,747,632.76 | 46,717,152.89 | 96,790,316.11 | 60,364,642.84 |
| 归属于母公司股东的净利润 | 12,713,011.49 | 46,719,608.82 | 96,778,082.38 | 60,362,924.24 |
| 少数股东损益 | 34,621.27 | -2,455.93 | 12,233.73 | 1,718.6 |
| (一)基本每股收益 | 0.05 | 0.18 | 0.36 | 0.23 |
| (二)稀释每股收益 | 0.05 | 0.18 | 0.36 | 0.23 |
| 九、综合收益总额 | 12,747,632.76 | 46,717,152.89 | 96,790,316.11 | 60,364,642.84 |
| 归属于母公司股东的综合收益总额 | 12,713,011.49 | 46,719,608.82 | 96,778,082.38 | 60,362,924.24 |
| 归属于少数股东的综合收益总额 | 34,621.27 | -2,455.93 | 12,233.73 | 1,718.6 |
| 公告日期 | 2025-04-29 | 2025-04-29 | 2024-10-30 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |